Clinical trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB…
NCT00324805 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00324805 |
|---|---|
| Title | Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery |
| Official title | A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (≥ 4 cm) - IIIA Non-small Cell Lung Cancer (NSCLC) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Cancer and Leukemia Group B NCIC Clinical Trials Group North Central Cancer Treatment Group SWOG Cancer Research Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7 |
| Intervention type | Biological, Drug, Other |
| Interventions | Bevacizumab, Cisplatin, Docetaxel, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pemetrexed Disodium, Questionnaire Administration, Vinorelbine Tartrate |
| Enrollment | 1,501 |
| Start date | Jul 19, 2007 |
| Primary completion | Oct 20, 2015 |
| Completion | Jan 31, 2025 |
| First posted | May 11, 2006 |
| Last update posted | Mar 3, 2025 |
| Countries | Canada, Ireland, Peru, South Africa, United States |
At a glance
- 1,000+ Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: